Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$3.66 +0.14 (+4.11%)
As of: Nov 11, 2026 · 10:50 AM EST

Verrica Pharmaceuticals (VRCA) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Verrica Pharmaceuticals' Depreciation & Amortization (CF) came in at $113,000 for Q2 2026, up 39.5% from $81,000 a year earlier and up 13.0% from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Verrica Pharmaceuticals reported Depreciation & Amortization (CF) of $401,000, down 18.0% year-over-year; for FY2025, it was $352,000, down 43.1% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 52.3% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $619,000 in FY2024 (+16.8%), $530,000 in FY2023 (+6.0%), $500,000 in FY2022 (+104.9%) and $244,000 in FY2021 (+467.4%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q4 2024.
  • Year-over-year, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 1.6%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 980.0%), and the weakest in Q3 2025 (a decline of 52.9%).
  • Business Quant data shows VRCA's Depreciation & Amortization (CF) at $100,000 (Q1 2026), $100,000 (Q4 2025) and $88,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Verrica Pharmaceuticals 60.47 Mn -22.58 Mn 5.43 Mn 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15,000.00
Mar 31, 2026 17,000.00
Dec 31, 2025 14,000.00
Sep 30, 2025 21,807.00
Jun 30, 2025 45,000.00
Mar 31, 2025 52,000.00
Dec 31, 2024 42,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 126,000.00
Dec 31, 2023 130,000.00
Sep 30, 2023 100,000.00
Jun 30, 2023 100,000.00
Mar 31, 2023 131,000.00
Dec 31, 2022 177,000.00
Sep 30, 2022 127,000.00
Jun 30, 2022 98,000.00
Mar 31, 2022 98,000.00
Dec 31, 2021 142,000.00
Sep 30, 2021 54,000.00
API Access

Verrica Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRCA&period=max&api_key=YOUR_API_KEY